Current status of therapeutic drug monitoring in mental health treatment: A review

F Pennazio, C Brasso, V Villari, P Rocca - Pharmaceutics, 2022 - mdpi.com
mental health, with particular attention to the most recent findings issued after the AGNP
guidelines. … after the issue of AGNP guidelines, enabling a clear and simple update on the topic. …

[HTML][HTML] … in clinical practice: a joint consensus statement of the American Society of Clinical Psychopharmacology and the Therapeutic Drug Monitoring Task Force of …

G Schoretsanitis, JM Kane, CU Correll… - … of clinical psychiatry, 2020 - psychiatrist.com
… American Psychiatric Association.1 Two decades later, the TDM taskforce of the AGNP
published a first consensus statement on TDM in neuropsychopharmacology,13 updated twice in …

Therapeutic drug monitoring and pharmacogenetics of antipsychotics and antidepressants in real life settings: A 5-year single centre experience

S Baldelli, S Cheli, C Montrasio… - … Biological Psychiatry, 2021 - Taylor & Francis
… (AGNP) has brought to the recently released latest versions of the therapeutic drug
monitoring (TDM) expert group consensus2011. Development of a LC-MS/MS method for …

A review of a recently published guidelines'“strong recommendation” for therapeutic drug monitoring of olanzapine, haloperidol, perphenazine, and fluphenazine

C Noel - Mental Health Clinician, 2019 - meridian.allenpress.com
… (TDM) guidelines for a number of psychiatric medications with the most recent update in
2017. … Therapeutic drug monitoring is a growing area of health care that may help clinicians …

Therapeutic Drug Monitoring in Psychiatry: Enhancing Treatment Precision and Patient Outcomes

L Biso, S Aringhieri, M Carli, M Scarselli, B Longoni - Pharmaceuticals, 2024 - mdpi.com
… (AGNP) was created to define the TDM consensus guidelines, which were initially published
in 2004 [4] and then updated … The AGNP consensus guidelines accept a therapeutic range …

[PDF][PDF] Current Status of Therapeutic Drug Monitoring in Mental Health Treatment: A Review. Pharmaceutics 2022, 14, 2674

F Pennazio, C Brasso, V Villari, P Rocca - 2022 - iris.unito.it
mental health, with particular attention to the most recent findings issued after the AGNP
guidelines. … after the issue of AGNP guidelines, enabling a clear and simple update on the topic. …

Therapeutic reference ranges for psychotropic drugs: a protocol for systematic reviews

XM Hart, L Eichentopf, X Lense, T Riemer… - … in Psychiatry, 2021 - frontiersin.org
… The only tool for such a personalization, which is now widely used in psychiatric clinical
practice, is therapeutic drug monitoring (TDM). TDM-guided therapies aim at titrating drug levels …

Automated Interlaboratory comparison of therapeutic drug monitoring data and its use for evaluation of published therapeutic reference ranges

JB Larsen, E Hoffmann-Lücke, PH Aaslo… - Pharmaceutics, 2023 - mdpi.com
… Defining and updating therapeutic reference ranges are difficult, and there is no standardised
… For the calculations, data were collected covering the period from 9 May 2011 to 26 April …

Status and Quality of Guidelines for Therapeutic Drug Monitoring Based on AGREE II Instrument

ZM Yi, X Li, Z Wang, J Qin, D Jiang, P Tian… - Clinical …, 2023 - Springer
updates based on Appraisal of Guidelines … , therapeutic drug monitoring (TDM) has been
widely used in clinical practice and has promoted the development of individualized medication

Therapeutic Drug Monitoring in Neuropsychiatric Disorders

S Kolachalam, S Aringhieri, M Scarselli - Brain and Heart Dynamics, 2020 - Springer
… recommended as indicated in AGNP consensus guidelines (Level I recommendation) [1]. …
Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: update